ASCENDIS PHARMA A/S's ticker is ASND and the CUSIP is 04351P101. A total of 182 filers reported holding ASCENDIS PHARMA A/S in Q1 2022. The put-call ratio across all filers is 0.64 and the average weighting 0.8%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $72,323,978 | -9.9% | 772,362 | -14.2% | 0.11% | -6.8% |
| Q2 2023 | $80,310,006 | +1.1% | 899,832 | +21.5% | 0.12% | -7.1% |
| Q1 2023 | $79,435,224 | -7.9% | 740,862 | +4.9% | 0.13% | -15.9% |
| Q4 2022 | $86,273,731 | +6.0% | 706,409 | -10.4% | 0.15% | -2.6% |
| Q3 2022 | $81,376,000 | +8.9% | 788,065 | -2.0% | 0.16% | +15.7% |
| Q2 2022 | $74,732,000 | +0.7% | 803,911 | +27.2% | 0.13% | +19.6% |
| Q1 2022 | $74,192,000 | +10.1% | 632,169 | +26.2% | 0.11% | +16.7% |
| Q4 2021 | $67,415,000 | -6.8% | 501,115 | +10.4% | 0.10% | -14.3% |
| Q3 2021 | $72,357,000 | +30.5% | 453,961 | +7.7% | 0.11% | +30.2% |
| Q2 2021 | $55,445,000 | +326.7% | 421,473 | +318.1% | 0.09% | +290.9% |
| Q1 2021 | $12,993,000 | -63.0% | 100,816 | -52.1% | 0.02% | -64.5% |
| Q4 2020 | $35,137,000 | -41.6% | 210,679 | -46.0% | 0.06% | -47.5% |
| Q3 2020 | $60,198,000 | -30.1% | 390,087 | -33.0% | 0.12% | -35.5% |
| Q2 2020 | $86,079,000 | +34.4% | 582,008 | +2.3% | 0.18% | +8.9% |
| Q1 2020 | $64,060,000 | +164.7% | 568,871 | +227.0% | 0.17% | +236.0% |
| Q4 2019 | $24,199,000 | +45.4% | 173,947 | +0.7% | 0.05% | +35.1% |
| Q3 2019 | $16,644,000 | -41.9% | 172,796 | -30.5% | 0.04% | -42.2% |
| Q2 2019 | $28,640,000 | +44.9% | 248,716 | +48.1% | 0.06% | +39.1% |
| Q1 2019 | $19,763,000 | +98.3% | 167,911 | +5.6% | 0.05% | +76.9% |
| Q4 2018 | $9,965,000 | -14.5% | 159,056 | -3.3% | 0.03% | +4.0% |
| Q3 2018 | $11,653,000 | +3420.5% | 164,463 | +774.4% | 0.02% | +2400.0% |
| Q2 2015 | $331,000 | +1.5% | 18,809 | 0.0% | 0.00% | 0.0% |
| Q1 2015 | $326,000 | – | 18,809 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 7,387,900 | $1,177,557,000 | 16.32% |
| Q Global Advisors, LLC | 66,714 | $10,634,000 | 8.85% |
| Ghost Tree Capital, LLC | 120,000 | $19,127,000 | 5.59% |
| Vivo Capital, LLC | 760,606 | $121,233,000 | 5.44% |
| Spyglass Capital Management LLC | 1,378,887 | $219,781,000 | 5.04% |
| Avoro Capital Advisors LLC | 1,980,000 | $315,592,000 | 4.96% |
| Eversept Partners, LP | 445,203 | $70,960,906 | 4.93% |
| Sofinnova Investments, Inc. | 499,824 | $79,667,000 | 4.72% |
| Eventide Asset Management | 1,748,648 | $278,717,000 | 3.68% |
| Baker Brothers Advisors | 4,541,604 | $723,886,000 | 3.18% |